Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study

OBJECTIVE: Hepatocellular carcinoma (HCC) is a major cause of death worldwide and its incidence is expected to increase globally. Aim of this study was to assess whether the implementation of screening policies and the improvement of treatment options translated into a real-world survival benefit in...

Descripción completa

Detalles Bibliográficos
Autores principales: De Toni, Enrico N, Schlesinger-Raab, Anne, Fuchs, Martin, Schepp, Wolfgang, Ehmer, Ursula, Geisler, Fabian, Ricke, Jens, Paprottka, Philipp, Friess, Helmut, Werner, Jens, Gerbes, Alexander L, Mayerle, Julia, Engel, Jutta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943246/
https://www.ncbi.nlm.nih.gov/pubmed/30878947
http://dx.doi.org/10.1136/gutjnl-2018-318193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943246/
https://www.ncbi.nlm.nih.gov/pubmed/30878947
http://dx.doi.org/10.1136/gutjnl-2018-318193

Ejemplares similares